Effect of L-dopa administration on growth hormone secretion in normal subjects and Parkinsonian patients.
作者信息
Cavagnini F, Peracchi M, Scotti G, Raggi U, Pontiroli A E, Bana R
出版信息
J Endocrinol. 1972 Sep;54(3):425-33. doi: 10.1677/joe.0.0540425.
PMID:5071365
Abstract
摘要
相似文献
1
Effect of L-dopa administration on growth hormone secretion in normal subjects and Parkinsonian patients.
J Endocrinol. 1972 Sep;54(3):425-33. doi: 10.1677/joe.0.0540425.
2
L-dopa induced growth hormone secretion. Comparison with insulin tolerance test, arginine infusion and sleep induced GH-secretion.
Acta Endocrinol (Copenh). 1974 Oct;77(2):241-9. doi: 10.1530/acta.0.0770241.
3
[Effect of L-dopa on pituitary TSH and GH secretion in Parkinson's disease].
Nihon Naibunpi Gakkai Zasshi. 1972 Jul 20;48(4):241-4. doi: 10.1507/endocrine1927.48.4_241.
4
Stimulation of human-growth-hormone secretion by L-dopa.左旋多巴对人体生长激素分泌的刺激作用。
N Engl J Med. 1970 Dec 24;283(26):1425-9. doi: 10.1056/NEJM197012242832602.
5
Corticosteroid and growth hormone secretion in patients treated with L-dopa.接受左旋多巴治疗患者的皮质类固醇和生长激素分泌
Klin Wochenschr. 1970 Dec 15;48(24):1454-6. doi: 10.1007/BF01484684.
6
Plasma growth hormone and insulin response to levodopa and amantadine.
J Neural Transm. 1973;34(2):145-51. doi: 10.1007/BF01244667.
7
L-dopa level in plasma, primary condition for the kinetic effect.血浆中左旋多巴水平，这是动力学效应的首要条件。
J Neural Transm. 1973;34(2):133-43. doi: 10.1007/BF01244666.
8
Treatment of Parkinsonism with a compound of L-dopa (Larodopa R) and a decarboxylase inhibitor (RO-46-4602).使用左旋多巴（美多巴R）和一种脱羧酶抑制剂（RO-46-4602）的化合物治疗帕金森症。
Acta Neurol Scand Suppl. 1972;51:121-2.
9
Dissociation of growth hormone and prolactin secretion in Parkinson's disease following chronic L-dopa therapy.长期左旋多巴治疗后帕金森病患者生长激素与催乳素分泌的分离
J Clin Endocrinol Metab. 1974 Aug;39(2):229-35. doi: 10.1210/jcem-39-2-229.
10
Effects of L-dopa on plasma growth hormones and insulin.
Acta Neurol Scand Suppl. 1972;51:125-6.
引用本文的文献
1
Increased growth hormone response to dopamine infusion in insulin-dependent diabetic subjects: indication of possible blood-brain barrier abnormality.胰岛素依赖型糖尿病患者对多巴胺输注的生长激素反应增强：提示可能存在血脑屏障异常。
J Clin Invest. 1980 Jan;65(1):146-53. doi: 10.1172/JCI109644.
2
Failure of amantadine to modify serum growth hormone and insulin levels.
Experientia. 1973 May 15;29(5):573. doi: 10.1007/BF01926672.
3
Effect of hypoglycaemia, TRH and levodopa on plasma growth hormone, prolactin, thyrotropin and cortisol in Parkinson's disease before and during therapy.低血糖、促甲状腺激素释放激素及左旋多巴对帕金森病治疗前及治疗期间血浆生长激素、催乳素、促甲状腺激素及皮质醇的影响
J Neurol. 1986 Jun;233(3):149-52. doi: 10.1007/BF00314421.
4
2,3 diphosphoglycerate in Parkinson's disease.帕金森病中的2,3-二磷酸甘油酸
J Neurol Neurosurg Psychiatry. 1976 Oct;39(10):952-7. doi: 10.1136/jnnp.39.10.952.
5
Dopaminergic stimulation of HGH in diabetes mellitus and in obesity.
Acta Diabetol Lat. 1977 May-Aug;14(3-4):137-43. doi: 10.1007/BF02581401.
6
Variation of blood glucose and serum growth hormone, prolactin and insulin in subjects with insulin-dependent diabetes, after OGTT and pretreatment with 2-Br-alpha-ergocryptine.
Acta Diabetol Lat. 1977 May-Aug;14(3-4):119-28. doi: 10.1007/BF02581399.
7
Endocrine aspects of bromocriptine therapy in Parkinsonism.帕金森病中溴隐亭治疗的内分泌方面
J Neural Transm. 1978;43(2):153-60. doi: 10.1007/BF01579074.
Zotero 插件